From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Infectious Diseases>
  4. Summary and Comment

Chlorhexidine Bathing in the ICU

Chlorhexidine bathing significantly reduced the acquisition of MRSA and VRE, and the incidence of VRE bacteremia, in ICU patients.

In previous single-center studies (both partially supported by industry), bathing ICU patients daily with chlorhexidine reduced the acquisition of vancomycin-resistant enterococci (VRE) (JW Infect Dis Feb 24 2006) and the incidence of catheter-associated bloodstream infection (JW Infect Dis Oct 31 2007). Investigators now report results from a CDC-funded multicenter study of this intervention.

Nurses in six ICUs at four academic medical centers performed daily bed bathing of all patients (from the neck down). A 6-month baseline period, during which nonmedicated soap and water were used, was followed by a 6-month intervention period using chlorhexidine gluconate (4 oz. of 4% solution mixed in warm water). Throughout the study period, surveillance cultures for VRE and methicillin-resistant Staphylococcus aureus (MRSA) were performed on ICU admission and then at least weekly or on ICU discharge.

Rates of MRSA and VRE acquisition were 32% and 50% lower, respectively, during the intervention period than during the baseline period (3.4 vs. 5.0 MRSA acquisitions/1000 patient days [P=0.046]; 2.2 vs. 4.4 VRE acquisitions/1000 patient days [P=0.008]). The VRE bacteremia rate decreased by 73% (from 2.1 to 0.6 cases/1000 patient days [P=0.0006]) after the introduction of chlorhexidine bathing, whereas the MRSA bacteremia rate remained low and unchanged throughout the study period (<0.5 cases/1000 patient days).

Comment: Although limited by its before/after study design, this multicenter study raises the level of evidence supporting daily chlorhexidine bathing in the ICU. Chlorhexidine bathing is an attractive preventive intervention: It is simple, low risk, and likely to be effective against the full range of bacterial pathogens colonizing ICU patients. As its use becomes more widespread, surveillance will be needed for the emergence of chlorhexidine resistance.

Daniel J. Diekema, MD, MS

Published in Journal Watch Infectious Diseases June 17, 2009

Citation(s):

Climo MW et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med 2009 Jun; 37:1858.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.